Federal contract award
W81XWH20C0145
ESKAPEE PATHOGENS ANTIGEN RESEARCH AND DEVELOPMENT SERVICES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Sep 30, 2020 |
| Current end date | Dec 29, 2025 |
| Potential end date | Dec 29, 2025 |
| Latest award activity | Sep 16, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 16, 2025 | P00006 | $0 | NON-PERSONAL SERVICES FOR THE DEVELOPMENT OF ANTIBODIES AGAINST ESKAPEE PATHOGENS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.